Frontline Irinotecan Liposome OKed in Mets Pancreatic Cancer Frontline Irinotecan Liposome OKed in Mets Pancreatic Cancer
The approval was based on improved overall and PFS with irinotecan liposome alongside oxaliplatin, fluorouracil, and leucovorin vs gemcitabine plus nab-paclitaxel.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news